June Brand

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · The Lancet Respiratory Medicine · 2015 · 424 citations · Full text

Pharmacy, Molecular Medicine, Pharmacotherapy +17

Amyloid-β ¹¹ C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin et al. · Neurology · 2015 · 152 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis

Eric W.F.W. Alton, Jeffrey M. Beekman, A. Christopher Boyd et al. · Thorax · 2016 · 146 citations · Full text

Pharmacy, Molecular Pharmaceutics, Translational Sciences +13

Dynamic compression counteracts IL-1β induced inducible nitric oxide synthase and cyclo-oxygenase-2 expression in chondrocyte/agarose constructs

Shah Arghandawi, June Brand, O.O. Akanji et al. · Arthritis Research & Therapy · 2008 · 53 citations · Full text

Life Sciences, Cell Biology, Orthopaedic Surgery +17

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · Efficacy and Mechanism Evaluation · 2016 · 45 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17